Urs Kerkmann

22 papers receiving 525 citations

Urs Kerkmann's Hit Papers

Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial 2022 · 134 citations
1340+1+2Years since publication4080120

Peers

Urs Kerkmann
Comparison fields: 5 of 74
  • Dermatology 364
  • Immunology and Allergy 116
  • Immunology 230
  • Rheumatology 131
  • Pathology and Forensic Medicine 70
Replace Bo Ri Kim with:
Bo Ri Kim South Korea
Narumol Silpa‐archa Thailand
James Tarbox United States
M Mattii Italy
Anna Michalak-Stoma Poland
Henz Germany
A.‐S. Darrigade France
Rachana Agrawal United States
Eva‐B. Bröcker Germany
Huiqun Ma China
Urs Kerkmann relative to Bo Ri Kim South Korea Bo Ri Kim's profile →
Citations per field
00.5×3.7×
Bo Ri Kim · 1×
Citations per year

Countries citing papers authored by Urs Kerkmann

Since Specialization
Citations

This map shows the geographic impact of Urs Kerkmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urs Kerkmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urs Kerkmann more than expected).

Fields of papers citing papers by Urs Kerkmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urs Kerkmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urs Kerkmann. The network helps show where Urs Kerkmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Urs Kerkmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Urs Kerkmann Line = papers co-authored together Urs Kerkmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
Hit paper breakdown →
2022134
2 200581
3 201379
4 201046
5 201145
6 200429
7 201623
8 202320
9 200720
10 202317
11 202111
12 201611
13 20238
14 20237
15 20234
16 20243
17 20232
18 20232
19 20242
20 20191

About Urs Kerkmann

Urs Kerkmann is a scholar working on Dermatology, Rheumatology, Physiology, Immunology and Pathology and Forensic Medicine, having authored 23 papers that have together received 547 indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (13 papers), Asthma and respiratory diseases (5 papers), Hair Growth and Disorders (4 papers), Psoriasis: Treatment and Pathogenesis (4 papers), Autoimmune Bullous Skin Diseases (4 papers), Allergic Rhinitis and Sensitization (3 papers), Skin Protection and Aging (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). The work is most often cited by research in Dermatology (364 citations), Immunology and Allergy (116 citations), Immunology (230 citations), Rheumatology (131 citations) and Pathology and Forensic Medicine (70 citations). Urs Kerkmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Marianne Placzek, Bernhard Przybilla, Kristian Reich, Klaus-Peter Gilbertz, Ekkehard Haen, Thomas Herzinger, Andrew Blauvelt, Howard Sofen, Marco DiBonaventura and Norito Katoh. Their work appears in journals such as Journal of Investigative Dermatology, British Journal of Dermatology, Journal of the American Academy of Dermatology, Journal of the European Academy of Dermatology and Venereology and Dermatology and Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact